Overview

Yasmin 20 Cycle Control - Yasmin 20 Versus Mercilon in Healthy Female Volunteers

Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
0
Participant gender:
Female
Summary
The purpose of this study is to compare bleeding pattern of contraceptive Yasmin 20 to a marketed comparator.
Phase:
Phase 3
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Bayer
Treatments:
Dacuronium
Drospirenone and ethinyl estradiol combination
Pancuronium
Criteria
Inclusion Criteria:

- Healthy female volunteer aged 18-35,

- Smokers 18-30

Exclusion Criteria:

- Contraindications for using hormonal contraceptives